ILMN Stock Recent News

China countered President Donald Trump's across-the-board tariffs on Chinese products with tariffs on select U.S. imports Tuesday, as well as announcing an antitrust investigation into Google and other trade measures.U.S. tariffs on products from Canada and Mexico were also set to go into effect Tuesday before Trump agreed to a 30-day pause as the two countries acted to appease his concerns about border security and drug trafficking. Trump planned to talk with Chinese President Xi Jinping in the next few days.The Chinese response was “measured,” said John Gong, a professor at the University of International Business and Economics in Beijing.

Shares of Calvin Klein parent PVH (PVH) and biotech firm Illumina (ILMN) fell when China announced that the companies were being added to its "unreliable entity" list.

China retaliated against US tariffs on Tuesday by imposing additional duties on American goods like coal, crude oil (BZ=F, CL=F), and farm equipment. Initially, President Donald Trump announced a 10% levy on imports from China.

China's Commerce Ministry said on Tuesday that it had put PVH Corp and Illumina on its unreliable entity list after the two companies took what it called "discriminatory measures against Chinese enterprises" and "damaged" legitimate rights and interests of Chinese companies.

Besides Wall Street's top -and-bottom-line estimates for Illumina (ILMN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) Chief Executive Andrew Newland talked with Proactive about the company's recent breakthrough in dual ctDNA and CTC DNA analysis on the Illumina platform. The six-month project overcame technical hurdles to achieve an end-to-end solution using Illumina's specialist lung cancer DNA kit, demonstrating its potential impact in a 27-patient study.

Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

A “Dividend and Dynamite” approach that pairs ultra‐yielding blue chips with top‐tier growth stocks, delivering not only robust current income but also strong long‐term appreciation and 3X more dividends over time. By systematically screening for safety, quality, and valuation, you minimize exposure to dividend cutters and overpriced stocks - reducing volatility and boosting overall returns. Combining high-yield and hyper-growth stocks offers stable returns, outperforming the S&P 500 with less volatility and higher income growth potential.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.